NL EN
Home About us     Our story: Chiesi Belgium     Working at a Great Place To Work     Chiesi Worldwide     Mission and values     History     B Corp Therapeutic areas      Respiratory      Neonatology      Rare diseases      Special care Sustainability     We Act     Climbing for Life     Annual reports Jobs Research & Development     Research & Development     Pipeline Media Contact
  • Home
  • |
  • Contact
  • |
  • SpeakUp&BeHeard
  • |
  • Chiesi Group
  • NL
  • EN
  • FR
Welcome to Chiesi
Belgium
Enter at least 3 characters
  • About us
    • Our story: Chiesi Belgium
    • Working at a Great Place To Work
    • Chiesi Worldwide
    • Mission and values
    • History
    • B Corp
  • Therapeutic areas
    • Respiratory
    • Neonatology
    • Rare diseases
    • Special care
  • Sustainability
    • We Act
    • Climbing for Life
    • Annual reports
  • Jobs
  • Research & Development
    • Research & Development
    • Pipeline
  • Media
  • Contact
  • Respiratory
    Within the area respiratory diseases Chiesi is specialized in, among others, the treatement of...
    Respiratory
    Within the area respiratory diseases Chiesi is specialized in, among others, the treatement of...
  • Neonatology
    Preterm babies are given maximum support thanks to extra care and medicines
    Neonatology
    Preterm babies are given maximum support thanks to extra care and medicines
  • Rare diseases
    People with rare diseases find new hope thanks to Chiesi ’s research & innovation.
    Rare diseases
    People with rare diseases find new hope thanks to Chiesi ’s research & innovation.
  • Special care
    Chiesi also focuses its attention on the treatment and care of patients suffering from...
    Special care
    Chiesi also focuses its attention on the treatment and care of patients suffering from...
  • NEWS
    Chiesi gives Putte a green boost with 1500 new...
  • NEWS
    Chiesi No. 23 in 2024 World’s Best...
  • NEWS
    Relaunch Action Over Words website
  • NEWS
    Chiesi opens Biotech Center of Excellence (Parma)
  • NEWS
    Bringing Sustainability and Strategy together to...
  • NEWS
    Chiesi Group announces the passing of Honorary...
  • NEWS
    Chiesi Global Rare Diseases Announces Publication...
  • NEWS
    Chiesi’s 2022 Sustainability Report: “Purpose...
  • NEWS
    Chiesi Farmaceutici S.p.A. Completes Acquisition...
  • NEWS
    2022 for Chiesi: The Group’s international...
© 2025 Chiesi SA/NV
Telecomlaan / Avenue Telecom 9 PO Box 4 1831 Diegem
Belgium
T +32 (0)2 788 42 00
info.be@chiesi.com
Approval n°: 1381/TCP/InfoBrochure/BE/03-2023
Laatste update: 26/11/2024
  • Terms of Use
  • Privacy and Cookie Policy
  • Reporting adverse events
  • Code of Interdependence
  • Anti-Bribery Policy
  • Transparency
  • Code of conduct
  • SpeakUp&BeHeard
  • PURCHASING CONDITIONS
CHIESI ON THE WEB
follow us on:
CHIESI ON THE WEB
Austria
Chiesi Pharmaceuticals GmbH
Belgium
Chiesi sa
Brazil
Chiesi Farmacêutica Ltda
Bulgaria
Chiesi Bulgaria Ltd.
China
Chiesi Pharmaceutical (Shanghai) Co., Ltd
Czech Republic
Chiesi CZ s.r.o.
France
Chiesi S.A.
Germany
Chiesi GmbH
Greece
Chiesi Hellas Pharmaceuticals S.A.
Hungary
Chiesi Hungary Kft.
Italy
-
Mexico
Chiesi Mexico S.A. de C.V.
Pakistan
Chiesi Pharmaceuticals (Pvt) Limited
Poland
Chiesi Polonia
Romania
Chiesi România S.r.l.
Russian Federetion
Chiesi Pharmaceuticals LLC
Slovak Republic
Chiesi Slovakia s.r.o
Slovenia
Chiesi Slovenija, d.o.o
Spain
Chiesi España S.A.
Sweden
Chiesi Pharma AB
The Netherlands
Chiesi Pharmaceuticals B.V.
Turkey
Chiesi İlaçTicaret Limited Sirketi  A.Ş.
United Kingdom
Chiesi Ltd
United States
Chiesi Usa Inc.